ReviewBreast cancer (Dove Medical Press)2021
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective.
Peng Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it